Your browser doesn't support javascript.
loading
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial.
Shi, Lei; Yuan, Xin; Yao, Weiqi; Wang, Siyu; Zhang, Chao; Zhang, Bo; Song, Jinwen; Huang, Lei; Xu, Zhe; Fu, Jun-Liang; Li, Yuanyuan; Xu, Ruonan; Li, Tian-Tian; Dong, Jinghui; Cai, Jianming; Li, Genshi; Xie, Yunbo; Shi, Ming; Li, Yonggang; Zhang, Yu; Xie, Wei-Fen; Wang, Fu-Sheng.
Afiliação
  • Shi L; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Yuan X; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Yao W; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; National Industrial Base for Stem Cell Engineering Products, Tianjin, China.
  • Wang S; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Zhang C; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Zhang B; Department of Infectious Disease, General Hospital of Central Theater Command, Wuhan, China.
  • Song J; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Huang L; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Xu Z; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Fu JL; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China.
  • Li Y; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Xu R; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Li TT; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Scienc
  • Dong J; Department of Radiology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Cai J; Department of Radiology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Li G; Wuhan Kingmed Center for Clinical Laboratory Co., Ltd., Wuhan, China.
  • Xie Y; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Shi M; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Li Y; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China.
  • Zhang Y; National Industrial Base for Stem Cell Engineering Products, Tianjin, China; VCANBIO Cell&Gene Engineering Corp., Ltd., Tianjin, China.
  • Xie WF; Department of Gastroenterology, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China; Optical Valley Branch of Maternal and Child Hospital of Hubei Province, Wuhan, China. Electronic address: weifenxie@medmail.com.cn.
  • Wang FS; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No.100 Western 4th Ring Road, Beijing 100039, China; Wuhan Huoshenshan Hospital, Wuhan, China. Electronic address: fswang302@163.com.
EBioMedicine ; 75: 103789, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34963099

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article